Table of Contents
1. Introduction
- 1.1 Statement of Report
- 1.2 Objectives of this Report
- 1.3 Scope of the Report
- 1.4 Methodology
- 1.5 Executive Summary
2. Home Medical Testing Devices Markets
3. Home Medical Testing Devices Market Segments
- 3.1 Overview
- 3.2 World Markets
- 3.2.1 Major Markets for the Home Medical Testing Devices Segment
- 3.2.2 Global Trends
- 3.3 The U.S. Market
- 3.4 World Markets
- 3.4.1 Asia/Southeast Asia
- 3.4.1.1 Japan
- 3.4.1.2 China
- 3.4.1.3 Taiwan
- 3.4.1.4 India
- 3.4.2 Australia/New Zealand
- 3.4.3 Western Europe
- 3.4.4 Eastern Europe
- 3.4.5 Middle East
4. Technology Issues
- 4.1 Component Issues
- 4.2 Production Methods
- 4.3 cGMPs in Use
- 4.4 Testing
- 4.5 Shipping/Handling/Storage Environment Concerns
- 4.6 Use Environment-Unique Issues
- 4.6.1 IFUs
- 4.6.2 Electro Magnetic Compatibility
- 4.6.3 Product Support-Helpline
- 4.6.4 Preventive Maintenance
- 4.6.5 Back-up
- 4.6.6 Family Support
- 4.6.7 Medical Review
- 4.7 EMI/EMC
- 4.8 Risk Management (ISO 14971:2007)
- 4.9 Categories of Products
- 4.9.1 Alcohol Test Kits
- 4.9.2 Allergy Test Kits
- 4.9.3 Amniotic Fluid Leak Detectors
- 4.9.4 Anemia Meters
- 4.9.5 Apnea Therapy Equipment
- 4.9.6 Asthma Monitors
- 4.9.7 Blood Pressure Monitors
- 4.9.8 Breast Self-Examination Tools
- 4.9.9 Blood Typing Kits
- 4.9.10 Chlamydia
- 4.9.11 Cholesterol Tests
- 4.9.12 Defibrillators (Patient Use)
- 4.9.13 Diabetes Test Kits
- 4.9.14 Drugged Drink Test Kits
- 4.9.15 Electro Cardiogram
- 4.9.16 Gonorrhea Test
- 4.9.17 Hepatitis C Test
- 4.9.18 HIV (AIDS)
- 4.9.19 Influenza (Flu) Test Kits
- 4.9.20 Infusion Pumps
- 4.9.21 Kidney Dialysis
- 4.9.22 Kidney Disease Test Kits
- 4.9.23 Occult (Stool) Blood Screening Test Kits
- 4.9.24 Paternity (DNA) Test Kits
- 4.9.25 Pregnancy and Fertility Diagnostics
- 4.9.26 Pressure Pump and Pad System (for Bed Sores)
- 4.9.27 Prostate Cancer Screening Test Kit
- 4.9.28 Remote Monitoring Services
- 4.9.29 Spirometers
- 4.9.30 Thermometers
- 4.9.31 Thyroid Test Kits
- 4.9.32 Urinalysis Test Kit
- 4.9.33 Vaginal Infections
- 4.9.34 Wheelchairs
- 4.10 Future Directions
- 4.10.1 New Diabetes Testing Technologies
- 4.10.2 Quick Cholesterol Testers
- 4.10.3 Adsorbers
- 4.10.4 Remote Health Monitoring/Screening
5. Business Trends
- 5.1 Market Drivers
- 5.1.1 Medical/Clinical Studies
- 5.1.2 Sports
- 5.1.3 Demographics
- 5.1.4 Market Restraints
- 5.2 Market Prospects
- 5.3 Marketing and Distribution
- 5.4 Competitive Landscape
- 5.5 Business Developments
- 5.6 Acquisitions and Partnerships
6. Home Medical Testing Kits and Devices, Regulation and Reimbursement
- 6.1 Market Segments
- 6.1.1 Test Kits/Diagnostics
- 6.1.2 Devices
- 6.1.3 Equipment
- 6.2 Customer Needs
- 6.3 Competitor Analysis
- 6.4 Pricing Pressures (Based on the U.S. Model)
- 6.4.1 "Big Box" Retailing
- 6.4.2 Internet
- 6.4.3 Mail Order
- 6.4.4 Chain Retail Outlets (Grocery, Dedicated)
- 6.4.5 "Mom and Pop" (Stand Alone) Health (Food) Stores
- 6.4.6 MLM (Multi Level Marketing)
- 6.5 BSE and Gelatin-based Ingested (or Body Fluid Contact) Products
- 6.6 Home Care Providers
- 6.7 Medicare-certified Agencies
- 6.8 Types of Home Healthcare Organizations
- 6.9 Non-Medicare-certified Agencies
- 6.9.1 Medicare Home Health Prospective Payment
- 6.9.2 U.S. Medicaid Home Care
- 6.9.3 Managed Care
- 6.10 Third-Party Reimbursement
- 6.11 Regulation Trends
- 6.11.1 U.S. FDA Policy
- 6.11.2 GMPs
- 6.11.3 Current Progress
- 6.11.4 Future Regulatory Trends
- 6.11.5 Key Issues
- 6.11.6 Labeling Requirements
- 6.12 Market Trends
7. Corporate Profiles
- 7.1 Abbott Laboratories
- 7.2 Apria Healthcare
- 7.3 Baxter International, Inc.
- 7.4 Braun
- 7.5 Del Mar Reynolds Medical Ltd.
- 7.6 Fresenius Medical Care
- 7.7 Gambro AB
- 7.8 Graham-Field Health Products
- 7.9 Gentiva Health Services, Inc.
- 7.10 General Nutrition Centers, Inc.
- 7.11 Invacare Corporation
- 7.12 Kimberly-Clark Corporation
- 7.13 Lincare
- 7.14 Matria Healthcare
- 7.15 Respironics
- 7.16 Sunrise Medical
Appendix 1: Overview of the U.S. FDA Good Manufacturing Practices
(GMP)/Quality System (QS) Regulation (21 CFR Part 820)
Appendix 2: The U.S. FDA GMPs, 21 CFR Part 820
Appendix 3: FDA Guidelines for Device Use in the Home
Appendix 4: ISO 14971 Medical Device Risk Management
INDEX OF TABLES
- Table 3.1: Comparison of Procedure Costs-U.S. and Overseas, 2006 and 2007
- Table 5.1: Market Drivers
- Table 5.2: Market Restraints
|